- Home
- ENLV vs FTEL Comparison
ENLV vs FTEL Comparison
Compare ENLV & FTEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENLV
- FTEL
- Stock Information
- Founded
- ENLV 2005
- FTEL 2007
- Country
- ENLV Israel
- FTEL Australia
- Employees
- ENLV N/A
- FTEL N/A
- Industry
- ENLV Biotechnology: Pharmaceutical Preparations
- FTEL
- Sector
- ENLV Health Care
- FTEL
- Exchange
- ENLV Nasdaq
- FTEL Nasdaq
- Market Cap
- ENLV 23.7M
- FTEL 19.3M
- IPO Year
- ENLV 1995
- FTEL 2023
- Fundamental
- Price
- ENLV $1.57
- FTEL $0.49
- Analyst Decision
- ENLV Strong Buy
- FTEL
- Analyst Count
- ENLV 2
- FTEL 0
- Target Price
- ENLV $10.00
- FTEL N/A
- AVG Volume (30 Days)
- ENLV 340.6K
- FTEL 567.3K
- Earning Date
- ENLV 08-29-2025
- FTEL 08-19-2025
- Dividend Yield
- ENLV N/A
- FTEL N/A
- EPS Growth
- ENLV N/A
- FTEL N/A
- EPS
- ENLV N/A
- FTEL N/A
- Revenue
- ENLV N/A
- FTEL $4,990,695.00
- Revenue This Year
- ENLV N/A
- FTEL N/A
- Revenue Next Year
- ENLV N/A
- FTEL N/A
- P/E Ratio
- ENLV N/A
- FTEL N/A
- Revenue Growth
- ENLV N/A
- FTEL 29.02
- 52 Week Low
- ENLV $0.81
- FTEL $0.36
- 52 Week High
- ENLV $1.76
- FTEL $49.50
- Technical
- Relative Strength Index (RSI)
- ENLV 68.20
- FTEL 39.82
- Support Level
- ENLV $1.31
- FTEL $0.66
- Resistance Level
- ENLV $1.66
- FTEL $0.53
- Average True Range (ATR)
- ENLV 0.13
- FTEL 0.10
- MACD
- ENLV 0.01
- FTEL -0.03
- Stochastic Oscillator
- ENLV 83.33
- FTEL 6.96
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
About FTEL Fitell Corporation
Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains. The company earns maximum of revenue for retail.